Ann Thorac Surg 2004;78:946-947
© 2004 The Society of Thoracic Surgeons
Invited commentary
Flavian M. Lupinetti, MD
Phoenix Children's Hospital, 1920 E Cambridge Ave, Suite 304, Phoenix, AZ 85016, USA
fmlupinetti@hotmail.com
| The first 20% of the full text of this article appears below. |
Suda and colleagues have produced an intriguing investigation of the relationship of vascular endothelial growth factor (VEGF) in patients with cyanosis and the palliative or reparative operations that these patients receive. The topic is an important one, in that VEGF has been hypothesized to play at least a contributory role in the pathophysiology of pulmonary arteriovenous malformations (PAVM). Because PAVM are known to regress in . . . [Full Text of this Article]
Related Article
-
Increased vascular endothelial growth factor in patients with cyanotic congenital heart diseases may not be normalized after a Fontan type operation
- Kenji Suda, Masahiko Matsumura, Setsuko Miyanish, Kyokun Uehara, Takaaki Sugita, and Masahiko Matsumoto
Ann. Thorac. Surg. 2004 78: 942-946.
[Abstract]
[Full Text]
[PDF]
Copyright © 2004 by The Society of Thoracic Surgeons.